Search

Michael K Rycyzyn

from San Diego, CA
Age ~35
Get Report
Also known as:
Michael Kenneth Rycyzyn, Mike Rycyzyn
Related to:
Diane L MorrisJohn Gilbert Morris, 67Anna Rycyzyn, 33Debbie RycyzynKenneth M Rycyzyn, 74Deborah Rycyzyn, 69E N
Connected to:
Maureen A Ryczaj, 64Karen C Ryczak, 65Kristen M Ryczak, 41Robert A Ryczak, 76Joseph P Ryczek, 67Karen J Ryczek, 58Robert L Ryczek, 70Katarzyna Ryczkowski, 45Joseph H Ryczywot, 53Wesley H Ryd, 95

Michael Rycyzyn Phones & Addresses

  • San Diego, CA
  • 11818 Dorothy St APT 208, Los Angeles, CA 90049
  • Santa Monica, CA
  • Tucson, AZ

Work

Company: A+e networks Mar 2018 Position: Senior manager, digital content licensing and distribution

Education

Degree: Bachelors, Bachelor of Science School / High School: University of Arizona 2008 to 2012 Specialities: Business Marketing

Skills

Sales • Social Media • Microsoft Excel • Wide Orbit • Microsoft Office • Advertising • Facebook • Powerpoint • Marketing • Customer Service • Sales Operations • Microsoft Word • Event Planning • Social Networking • One Domain • Public Speaking • Social Media Marketing

Interests

Media and Entertainment Sales

Industries

Entertainment

Resumes

Resumes

Michael Rycyzyn Photo 1

Senior Manager, Digital Content Licensing And Distribution

View page
Location:
Los Angeles, CA
Industry:
Entertainment
Work:
A+E Networks
Senior Manager, Digital Content Licensing and Distribution
A+E Networks Jan 2015 - Nov 2015
Sales Service Representative
A+E Networks Jan 2015 - Nov 2015
Integrated Sales Planner
Katz Media Group Aug 2012 - Dec 2014
Sales Assistant
Xetv-San Diego 6 Cw Jun 2011 - Aug 2011
Promotions Intern
Education:
University of Arizona 2008 - 2012
Bachelors, Bachelor of Science, Business Marketing Torrey Pines High School 2008
John Cabot University
Skills:
Sales
Social Media
Microsoft Excel
Wide Orbit
Microsoft Office
Advertising
Facebook
Powerpoint
Marketing
Customer Service
Sales Operations
Microsoft Word
Event Planning
Social Networking
One Domain
Public Speaking
Social Media Marketing
Interests:
Media and Entertainment Sales

Publications

Us Patents

Human Anti-Cd27 Antibodies, Methods And Uses

View page
US Patent:
20130243795, Sep 19, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/835518
Inventors:
Johan Fransson - San Diego CA, US
Natalie Fursov - Spring House PA, US
Damon Hamel - San Diego CA, US
Thomas Malia - Spring House PA, US
Galina Obmolova - Spring House PA, US
Tatiana Ort - Spring House PA, US
Michael Rycyzyn - Spring House PA, US
Michael Scully - Spring House PA, US
Raymond Sweet - Spring House PA, US
Alexey Teplyakov - Spring House PA, US
John Wheeler - Spring House PA, US
Juan Carlos Almagro - Brookline MA, US
Assignee:
JANSSEN BIOTECH, INC. - Horsham PA
International Classification:
C07K 16/28
US Classification:
4241731, 5303898, 536 2353, 4353201, 435334, 435 696, 435375
Abstract:
Human antibodies immunospecific for human CD27 are capable of blocking CD27 binding to its ligand CD70 and neutralizing bioactivity of CD27 including, but not limited to, CD27 intracellular signaling, T-cell proliferation and activation, B-cell proliferation and differentiation, plasmablast formation and alleviation of antibody responses, stimulation of tumor cells by CD70, and the production of soluble mediators from T and B-cells. The antibodies are useful in diagnosing or treating CD27 activity associated diseases and conditions.

Human Anti-Cd27 Antibodies, Methods And Uses

View page
US Patent:
20150299330, Oct 22, 2015
Filed:
Jul 2, 2015
Appl. No.:
14/790144
Inventors:
- HORSHAM PA, US
Johan Fransson - San Diego CA, US
Natalie Fursov - Spring House PA, US
Damon Hamel - San Diego CA, US
Thomas Malia - Spring House PA, US
Galina Obmolova - Spring House PA, US
Tatiana Ort - Spring House PA, US
Michael Rycyzyn - Spring House PA, US
Michael Scully - Spring House PA, US
Raymond Sweet - Spring House PA, US
Alexey Teplyakov - Spring House PA, US
John Wheeler - Spring House PA, US
Juan Carlos Almagro - Brookline MA, US
International Classification:
C07K 16/28
Abstract:
Human antibodies immunospecific for human CD27 are capable of blocking CD27 binding to its ligand CD70 and neutralizing bioactivity of CD27 including, but not limited to, CD27 intracellular signaling, T-cell proliferation and activation, B-cell proliferation and differentiation, plasmablast formation and alleviation of antibody responses, stimulation of tumor cells by CD70, and the production of soluble mediators from T and B-cells. The antibodies are useful in diagnosing or treating CD27 activity associated diseases and conditions.
Control profile
Michael K Rycyzyn from San Diego, CA, age ~35 Get Report